HK1053648A1 - Novel 1-(1-(hetero)aryl-1-perhydroxyalkylmethyl)-piperazine compounds, process for their preparationand medicaments containing these compounds - Google Patents

Novel 1-(1-(hetero)aryl-1-perhydroxyalkylmethyl)-piperazine compounds, process for their preparationand medicaments containing these compounds

Info

Publication number
HK1053648A1
HK1053648A1 HK03105680A HK03105680A HK1053648A1 HK 1053648 A1 HK1053648 A1 HK 1053648A1 HK 03105680 A HK03105680 A HK 03105680A HK 03105680 A HK03105680 A HK 03105680A HK 1053648 A1 HK1053648 A1 HK 1053648A1
Authority
HK
Hong Kong
Prior art keywords
compounds
perhydroxyalkylmethyl
preparationand
hetero
aryl
Prior art date
Application number
HK03105680A
Other languages
English (en)
Inventor
Daniel Jasserand
Ulf Preuschoff
Jochen Antel
Samuel David
Holger Sann
Reinhard Bruckner
Dania Reiche
Christian Eeckhout
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of HK1053648A1 publication Critical patent/HK1053648A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
HK03105680A 2001-09-13 2003-08-08 Novel 1-(1-(hetero)aryl-1-perhydroxyalkylmethyl)-piperazine compounds, process for their preparationand medicaments containing these compounds HK1053648A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10145044A DE10145044A1 (de) 2001-09-13 2001-09-13 Neue 1-[1-(Hetero)aryl-1-perhydroxyalkylmethyl]-Piperazinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
HK1053648A1 true HK1053648A1 (en) 2003-10-31

Family

ID=7698848

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03105680A HK1053648A1 (en) 2001-09-13 2003-08-08 Novel 1-(1-(hetero)aryl-1-perhydroxyalkylmethyl)-piperazine compounds, process for their preparationand medicaments containing these compounds

Country Status (27)

Country Link
US (1) US6770649B2 (fr)
EP (1) EP1293506B1 (fr)
JP (1) JP4353684B2 (fr)
KR (1) KR100909746B1 (fr)
CN (1) CN1232513C (fr)
AR (1) AR036487A1 (fr)
AT (1) ATE305464T1 (fr)
AU (1) AU2002301141B2 (fr)
BR (1) BR0203716A (fr)
CA (1) CA2403139C (fr)
DE (2) DE10145044A1 (fr)
DK (1) DK1293506T3 (fr)
DZ (1) DZ3292A1 (fr)
ES (1) ES2250561T3 (fr)
HK (1) HK1053648A1 (fr)
HU (1) HU227612B1 (fr)
IL (1) IL151497A (fr)
MX (1) MXPA02008789A (fr)
NO (1) NO324867B1 (fr)
NZ (1) NZ521154A (fr)
PL (1) PL356018A1 (fr)
PT (1) PT1293506E (fr)
RU (1) RU2301807C2 (fr)
SI (1) SI1293506T1 (fr)
TW (1) TWI254046B (fr)
UA (1) UA75590C2 (fr)
ZA (1) ZA200206731B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1870396B1 (fr) * 2005-03-31 2012-10-31 Nippon Zoki Pharmaceutical Co. Ltd. Derive de la benzyloxypropylamine
US7592344B2 (en) 2005-11-30 2009-09-22 Solvay Pharmaceuticals Gmbh NK1 and NK2-antagonists and compositions and methods of using the same
ATE550324T1 (de) * 2005-11-30 2012-04-15 Abbott Products Gmbh Neue nk1- und nk2-antagonisten
CN103387549A (zh) * 2012-05-10 2013-11-13 广州医学院 三个苯并三氮唑类芳基哌嗪化合物的消旋体和光学异构体及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903957A1 (en) * 1989-11-06 1991-05-08 Sanofi Sa Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
EP0709375B1 (fr) * 1994-10-25 2005-05-18 AstraZeneca AB Hétérocycles thérapeutiquement actifs
DE60114597T2 (de) * 2000-04-06 2006-07-20 Astrazeneca Ab Naphthamid-neurokinin antagonisten zur verwendung als medikamente

Also Published As

Publication number Publication date
AR036487A1 (es) 2004-09-15
HUP0202967A3 (en) 2004-04-28
DK1293506T3 (da) 2005-10-17
HUP0202967A2 (hu) 2003-06-28
NO324867B1 (no) 2007-12-17
NO20024351L (no) 2003-03-14
DE50204379D1 (de) 2006-02-09
US20030125557A1 (en) 2003-07-03
NO20024351D0 (no) 2002-09-12
DE10145044A1 (de) 2003-04-03
ES2250561T3 (es) 2006-04-16
EP1293506A1 (fr) 2003-03-19
ZA200206731B (en) 2003-04-11
ATE305464T1 (de) 2005-10-15
AU2002301141B2 (en) 2008-11-06
KR20030023500A (ko) 2003-03-19
JP2003113160A (ja) 2003-04-18
CA2403139A1 (fr) 2003-03-13
HU227612B1 (en) 2011-09-28
EP1293506B1 (fr) 2005-09-28
KR100909746B1 (ko) 2009-07-29
NZ521154A (en) 2004-02-27
CN1406937A (zh) 2003-04-02
CN1232513C (zh) 2005-12-21
IL151497A0 (en) 2003-04-10
US6770649B2 (en) 2004-08-03
PL356018A1 (en) 2003-03-24
PT1293506E (pt) 2005-11-30
UA75590C2 (en) 2006-05-15
TWI254046B (en) 2006-05-01
MXPA02008789A (es) 2003-03-18
SI1293506T1 (sl) 2005-12-31
CA2403139C (fr) 2011-02-22
RU2301807C2 (ru) 2007-06-27
JP4353684B2 (ja) 2009-10-28
BR0203716A (pt) 2003-06-03
HU0202967D0 (fr) 2002-10-28
IL151497A (en) 2011-10-31
DZ3292A1 (fr) 2005-05-14
RU2002124199A (ru) 2004-03-20

Similar Documents

Publication Publication Date Title
EP1554281A4 (fr) Procede de preparation de certains composes de pyrrolotriazine
HK1081965A1 (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
IL164442A0 (en) Benzoxazinone-derived compounds, their preparationand use as medicaments
HUP0300002A3 (en) Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
AU2002333415A1 (en) Process for preparing 1-(carboxymethyl)- and 1-(aminocarbonyl)- pyrimidin-4-one derivatives
MXPA03006322A (es) Procedimiento mejorado para la sintesis de carbapenem.
HUP0500037A3 (en) Process for preparing insulin compounds
AU2003212310A1 (en) (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
AU5884700A (en) Process for making amine compounds
HUP0500329A3 (en) Process for making carbapenem compounds
HK1050682A1 (en) New octahydro-2h-pyridoÄ1,2-aÜpyrazine compounds, a process for their preparation and pharmaceuticalcompositions containing them.
HK1053648A1 (en) Novel 1-(1-(hetero)aryl-1-perhydroxyalkylmethyl)-piperazine compounds, process for their preparationand medicaments containing these compounds
HUP0202379A3 (en) New compounds, process for producing them and pharmaceutical compositions containing them
AU2002306687A1 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
HK1049159A1 (en) New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them.
HK1049000A1 (en) New isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them.
EG24207A (en) New benzothiazine and benazothiadizine compounds, a process for their preparation and pharmaceuticalcompositions containing them
ZA200205598B (en) Benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200205666B (en) N-benzylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them.
AU2002301141A1 (en) Novel 1-[-(hetero)aryl-1-perhydroxyalkylmethyl])-piperazine compounds, process for their preparation and medicaments containing these compounds
IL163334A (en) Process for preparing 1-(mercaptomethyl)- cyclopropaneacetic acid and intermediate compounds for use therein
HUP0001249A3 (en) Novel substituted dimeric compounds, process for their production and medicaments containing the same
HK1053646A1 (en) BenzoÄBÜpyranoÄ3,2-HÜacridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200308265B (en) Imidazoline compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200204757B (en) Indenoidolone compounds, a process for their preparation and pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110911